Data / Form D filings / Dicerna Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc: Form D filings
Dicerna Pharmaceuticals Inc, a pharmaceuticals company in Watertown, MA, filed 4 Form D notices with the SEC between 2010 and 2013. The latest, on August 15, 2013, reports $60 million sold of a $63 million offering to 13 investors.
Find out what Dicerna Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 480 ARSENAL ST. BUILDING 1, SUITE 120, Watertown, MA, 02472
- Phone
- (617) 621-8097
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1399529
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 15, 2013 | New notice | $63,000,000 | $59,999,937 | $3,000,063 | 13 | Jul 30, 2013 | sec.gov |
| Oct 28, 2010 | Amendment | $29,050,628 | $29,050,628 | $0 | 10 | Aug 5, 2010 | sec.gov |
| Aug 19, 2010 | New notice | $25,050,628 | $24,800,628 | $250,000 | 9 | Aug 5, 2010 | sec.gov |
| Jun 28, 2010 | New notice | $5,500,000 | $5,000,000 | $500,000 | 4 | Jun 17, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dennis H. Langer | Director | |
| Douglas Fambrough | Executive Officer, Director | |
| Jonathan MacQuitty | Director | |
| David K. Madden | Director | |
| Peter K. Kolchinsky | Director | |
| Brian K. Halak | Director | |
| Stephen K. Hoffman | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Aug 12, 2013 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Dicerna Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.